# clm_965E7901CE0F

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 5,020,800,000 United States dollar  
valid_from: 2011-12-31  
valid_to: 2012-12-31  
published: 2012-02-24  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1B4BD9A59709  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 5,020,800,000 United States dollar", as of 2011-12-31 (until 2012-12-31). Claim clm_965E7901CE0F, https://asof.is/claim/clm_965E7901CE0F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000119312512078393/0001193125-12-078393-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2011, filed 2012-02-24  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000119312512078393/0001193125-12-078393-index.htm (primary, SEC EDGAR 10-K FY2011, published 2012-02-24)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 4,884,200,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_965E7901CE0F](/claim/clm_965E7901CE0F.md) | [clm_E5BECE5372F5](/claim/clm_E5BECE5372F5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.